DNMT3B and prostate cancer: It has been reported that DNMT3b is upregulated and miR-145 is downregulated in prostate cancer cells [202,203], and either the repression of DNMT3b or the overexpression of miR-145 can suppress the proliferation and migration of PC3 cells [204,205].